BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7890012)

  • 1. Effects of bile salt and phospholipid hydrophobicity on lithogenicity of human gallbladder bile.
    van Erpecum KJ; Portincasa P; Stolk MF; van de Heijning BJ; van der Zaag ES; van den Broek AM; van Berge Henegouwen GP; Renooij W
    Eur J Clin Invest; 1994 Nov; 24(11):744-50. PubMed ID: 7890012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U; Sahlin S; Einarsson C
    Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cholesterol-phospholipid vesicles and cholesterol crystals in human gallbladder bile.
    Schriever CE; Jüngst D
    Hepatology; 1989 Apr; 9(4):541-6. PubMed ID: 2925158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid and phospholipid fatty acid composition in bile of patients with cholesterol and pigment gallstones.
    van Erpecum KJ; van Berge Henegouwen GP; Stolk MF
    Clin Chim Acta; 1991 Jul; 199(3):295-303. PubMed ID: 1769113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients.
    van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Schmidt YM; Willekens FL
    Hepatology; 1990 Jan; 11(1):1-6. PubMed ID: 2295460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile.
    Van Erpecum KJ; Portincasa P; Gadellaa M; Van de Heijning BJ; Van Berge Henegouwen GP; Renooij W
    Eur J Clin Invest; 1996 Jul; 26(7):602-8. PubMed ID: 8864423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular composition of biliary phosphatidylcholines, as related to cholesterol saturation, transport and nucleation in human gallbladder bile.
    Angelico M; Ginanni Corradini S; Masella R; Alvaro D; Cantafora A; Capocaccia L
    J Hepatol; 1992 May; 15(1-2):59-66. PubMed ID: 1506657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile concentration promotes nucleation of cholesterol monohydrate crystals by increasing the cholesterol concentration in the vesicles.
    Van Erpecum KJ; Stolk MF; van den Broek AM; Renooij W; van de Heijning BJ; van Berge Henegouwen GP
    Eur J Clin Invest; 1993 May; 23(5):283-8. PubMed ID: 8354334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile.
    Fischer S; Dolu MH; Zündt B; Meyer G; Geisler S; Jüngst D
    Eur J Clin Invest; 2001 Sep; 31(9):789-95. PubMed ID: 11589721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleation time and fatty acid composition of lecithin in human gallbladder bile.
    Hatsushika S; Tazuma S; Kajiyama G
    Scand J Gastroenterol; 1993 Feb; 28(2):131-6. PubMed ID: 8441906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile.
    Venneman NG; Portincasa P; Vanberge-Henegouwen GP; van Erpecum KJ
    Eur J Clin Invest; 2004 Oct; 34(10):656-63. PubMed ID: 15473890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of various cholesterol crystals in bile from patients with gallstones.
    Portincasa P; van Erpecum KJ; Jansen A; Renooij W; Gadellaa M; vanBerge-Henegouwen GP
    Hepatology; 1996 Apr; 23(4):738-48. PubMed ID: 8666327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
    Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
    Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt-rich model bile.
    Konikoff FM; Cohen DE; Carey MC
    J Lipid Res; 1994 Jan; 35(1):60-70. PubMed ID: 8138723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in gallbladder bile lithogenicity in patients after gastrectomy and colectomy.
    Chijiiwa K; Makino I; Kozaki N; Tanaka M
    Eur Surg Res; 1996; 28(1):1-7. PubMed ID: 8682139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.
    Carey MC; Small DM
    J Clin Invest; 1978 Apr; 61(4):998-1026. PubMed ID: 659586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of bile salt hydrophobicity in distribution of phospholipid species to carriers in supersaturated model bile solutions.
    Tsuchimoto D; Tazuma S; Yamashita G; Kajiyama G
    J Gastroenterol Hepatol; 1999 Apr; 14(4):388-93. PubMed ID: 10207791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types.
    van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Stolk MF; Eggink WF; Govaert WH
    Scand J Gastroenterol; 1988 Oct; 23(8):948-54. PubMed ID: 3201132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hydrophobic and hydrophilic bile salts on gallstone growth and dissolution in model biles.
    Venneman NG; van Kammen M; Renooij W; Vanberge-Henegouwen GP; van Erpecum KJ
    Biochim Biophys Acta; 2005 Jan; 1686(3):209-19. PubMed ID: 15629690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones.
    Portincasa P; Di Ciaula A; Vendemiale G; Palmieri V; Moschetta A; Vanberge-Henegouwen GP; Palasciano G
    Eur J Clin Invest; 2000 Apr; 30(4):317-24. PubMed ID: 10759880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.